Half Year Trading Update

EMIS Group PLC

11 July 2023

 

11 July 2023

EMIS Group plc

("EMIS Group" or "the Group")

Half Year Trading update

EMIS Group plc (AIM: EMIS.L), the UK leader in connected healthcare software and services, today announces a trading update for the six months ended 30 June 2023.

Trading for the half year was in line with the Board's expectations, consistent with previous guidance that growth for the year would be more weighted to the second half. The Group retained its leading positions in specialist markets, benefitted from high levels of recurring revenue and remains in a strong financial position, with net cash at 30 June 2023 of £48.5m (30 June 2022: £53.6m). 

In EMIS Health, the Group is continuing to invest in its technology and cloud refresh strategy to support its customers across the NHS. Modest revenue growth was held back by the ongoing steady planned reduction in lower margin resale partner activities. Encouragingly, the delivery run rate of previously secured digitisation contracts increased towards the end of the half year.

In EMIS Enterprise, the Group continues to grow its analytics business, and won new market share in Community Pharmacy for delivery in the second half. Performance in Partners and Pinnacle remained robust although below levels in the comparative period which benefitted from some significant one-offs.

In terms of the Recommended acquisition of EMIS Group announced on 17 June 2022, pursuant to which a wholly‐owned subsidiary of UnitedHealth Group will acquire EMIS, there is no further update to that provided on 25 May 2023.

For further information, contact:

EMIS Group plc                                                                                Tel: [phone]

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

@EMISGroup

Numis Securities Limited (Nominated Adviser & Broker)           Tel: [phone]

Josh Hughes/Simon Willis

MHP                                                                                                    Tel: [phone]

Reg Hoare/Ollie Hoare/Matthew Taylor/Pauline Guenot                                           [e-mail]       

Information for investors can be found on the Group's website at www.emisgroupplc.com/investors.

Notes to Editors

EMIS Group has grown to become a UK leader in connected healthcare software and systems. Its solutions are widely used across a number of major UK healthcare settings. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.

EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.

EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.

EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services, data and analytics, and research and life sciences.  

LEI: 213800K474ZZK76NX913

 

END